Soc. Generale Knock-Out ECV/ DE000SU01906 /
18.06.2024 21:46:30 | Изменение+0.160 | Бид21:59:03 | Предложение- | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
6.750EUR | +2.43% | 6.750 Величина цены спроса: 500 |
- Величина цены предложения: - |
ENCAVIS AG INH. O.N... | 10.5255 EUR | 31.12.2078 | Call |
GlobeNewswire
22:30
Trump Media & Technology Group Corp. Announces SEC Effectiveness of Amended Form S-1
GlobeNewswire
22:30
Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
GlobeNewswire
22:30
Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Comb...
GlobeNewswire
22:30
EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneu...
GlobeNewswire
22:15
Kite Realty Group Trust to Report Second Quarter 2024 Financial Results on July 30, 2024
GlobeNewswire
22:12
FSLY Investor Alert: Securities Fraud Class Action Lawsuit Was Filed Against Fastly, Inc. Investors ...
GlobeNewswire
22:10
Vislink Technologies, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:08
Brookfield Infrastructure Corporation Announces Results of Annual Meeting of Shareholders
GlobeNewswire
22:08
SPT Investors Alert: Securities Fraud Class Action Lawsuit Was Filed Against Sprout Social, Inc. (SP...
GlobeNewswire
22:08
LifeSave Kansas Now Carries Life-Saving Whole Blood Onboard All Transports Across the State
GlobeNewswire
22:05
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
GlobeNewswire
22:05
Euroseas Ltd. Announces Time Charter Contract for its third Fuel Efficient 1,800 teu Feeder Containe...
GlobeNewswire
22:05
Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NR...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница